Vericel (VCEL) Revenue (2011 - 2026)
Vericel recorded quarterly Revenue of $68.4 million in Q1 2026, down 26.36% quarter-over-quarter from $92.9 million in Q4 2025, and up 30.09% year-over-year from $52.6 million in Q1 2025.
Vericel's Revenue history runs 16 years deep, the most recent figure standing at $68.4 million for Q1 2026.
- In Q1 2026, Revenue rose 30.09% year-over-year to $68.4 million; the TTM figure through Mar 2026 stood at $292.1 million (up 22.45% YoY), while the FY2025 annual figure was $276.3 million, up 16.45% from the prior year.
- Revenue came in at $68.4 million for Q1 2026 at Vericel, down from $92.9 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $92.9 million in Q4 2025 to a low of $35.9 million in Q1 2022.
- A 5-year average of $55.5 million and a median of $52.7 million in 2024 frame the typical range for Revenue.
- Across the five-year window, Revenue fell 6.26% in 2022 and surged 30.09% in 2026, its largest moves.
- Vericel's Revenue stood at $52.7 million in 2022, then rose by 23.35% to $65.0 million in 2023, then climbed by 15.97% to $75.4 million in 2024, then increased by 23.27% to $92.9 million in 2025, then decreased by 26.36% to $68.4 million in 2026.
- According to Business Quant data, Revenue over the past three periods registered $68.4 million, $92.9 million, and $67.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.17 Bn |
| 10 | Vericel | 1.69 Bn | 1.55 Bn | 49.27 Mn | 68.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.43 Mn |
| Dec 31, 2025 | 92.92 Mn |
| Sep 30, 2025 | 67.50 Mn |
| Jun 30, 2025 | 63.24 Mn |
| Mar 31, 2025 | 52.60 Mn |
| Dec 31, 2024 | 75.38 Mn |
| Sep 30, 2024 | 57.91 Mn |
| Jun 30, 2024 | 52.66 Mn |
| Mar 31, 2024 | 51.28 Mn |
| Dec 31, 2023 | 65.00 Mn |
| Sep 30, 2023 | 45.58 Mn |
| Jun 30, 2023 | 45.92 Mn |
| Mar 31, 2023 | 41.02 Mn |
| Dec 31, 2022 | 52.69 Mn |
| Sep 30, 2022 | 38.55 Mn |
| Jun 30, 2022 | 37.05 Mn |
| Mar 31, 2022 | 35.85 Mn |
| Dec 31, 2021 | 47.59 Mn |
| Sep 30, 2021 | 34.51 Mn |
| Jun 30, 2021 | 39.52 Mn |
| Mar 31, 2021 | 33.63 Mn |
| Dec 31, 2020 | 45.23 Mn |
| Sep 30, 2020 | 32.26 Mn |
| Jun 30, 2020 | 20.01 Mn |
| Mar 31, 2020 | 26.68 Mn |
| Dec 31, 2019 | 39.39 Mn |
| Sep 30, 2019 | 30.50 Mn |
| Jun 30, 2019 | 26.15 Mn |
| Mar 31, 2019 | 21.81 Mn |
| Dec 31, 2018 | 31.34 Mn |
| Sep 30, 2018 | 22.48 Mn |
| Jun 30, 2018 | 19.01 Mn |
| Mar 31, 2018 | 18.03 Mn |
| Dec 31, 2017 | 23.35 Mn |
| Sep 30, 2017 | 14.26 Mn |
| Jun 30, 2017 | 16.95 Mn |
| Mar 31, 2017 | 9.36 Mn |
| Dec 31, 2016 | 23.35 Mn |
| Sep 30, 2016 | 10.93 Mn |
| Jun 30, 2016 | 12.82 Mn |
| Mar 31, 2016 | 14.11 Mn |
| Dec 31, 2015 | 15.42 Mn |
| Sep 30, 2015 | 11.31 Mn |
| Jun 30, 2015 | 13.59 Mn |
| Mar 31, 2015 | 10.85 Mn |
| Dec 31, 2014 | 14.71 Mn |
| Sep 30, 2014 | 9.66 Mn |
| Jun 30, 2014 | 4.43 Mn |
| Dec 31, 2013 | 8,000.00 |
| Jun 30, 2013 | 3,000.00 |
| Mar 31, 2013 | 8,000.00 |
| Dec 31, 2012 | 19,000.00 |
| Mar 31, 2012 | 2,000.00 |
| Sep 30, 2011 | 9,000.00 |
| Mar 31, 2011 | 9,000.00 |